Cargando…

The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD

Obesity and type 2 diabetes mellitus (T2DM) are metabolic disorders characterized by metabolic inflexibility with multiple pathological organ manifestations, including non-alcoholic fatty liver disease (NAFLD). Nuclear receptors are ligand-dependent transcription factors with a multifaceted role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, Emmanuel D., Nardo, Alexander D., Claudel, Thierry, Trauner, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145571/ https://www.ncbi.nlm.nih.gov/pubmed/33926085 http://dx.doi.org/10.3390/genes12050645

Ejemplares similares

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
por: Cariello, Marica, et al.
Publicado: (2021)

The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
por: Xu, Pengfei, et al.
Publicado: (2018)

Nuclear Receptor Regulation of Aquaglyceroporins in Metabolic Organs
por: Tardelli, Matteo, et al.
Publicado: (2018)

Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα
por: Goldwasser, Jonathan, et al.
Publicado: (2010)

The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism()()
por: Huang, Jianfeng, et al.
Publicado: (2013)

The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
por: Östlund, Cecilia, et al.
Publicado: (2020)

Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta
por: Shchelkunova, Tatyana A., et al.
Publicado: (2013)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

Bile acid transporters and regulatory nuclear receptors in the liver and beyond
por: Halilbasic, Emina, et al.
Publicado: (2013)

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα
por: Li, Ting, et al.
Publicado: (2020)

LXRα and LXRβ Nuclear Receptors Evolved in the Common Ancestor of Gnathostomes
por: Fonseca, Elza, et al.
Publicado: (2017)

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
por: Régnier, Marion, et al.
Publicado: (2020)

HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD
por: Agarwal, Neeti, et al.
Publicado: (2017)

Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages
por: Mota, Ana Carolina, et al.
Publicado: (2021)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease
por: Tardelli, Matteo, et al.
Publicado: (2020)

Insights into the Role of PPARβ/δ in NAFLD
por: Chen, Jiapeng, et al.
Publicado: (2018)

Skeletal muscle insulin resistance in hamsters with diabetes developed from obesity is involved in abnormal skeletal muscle LXR, PPAR and SREBP expression
por: LI, GUO-SHENG, et al.
Publicado: (2016)

Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice
por: Tardelli, Matteo, et al.
Publicado: (2021)

Nuclear-lipid-droplet proteome: carboxylesterase as a nuclear lipase involved in lipid-droplet homeostasis
por: Lagrutta, Lucía C., et al.
Publicado: (2021)

Study of serum visfatin and blood glucose and lipid metabolism, nafld in simple obese children
por: Li, Rui-zhen, et al.
Publicado: (2015)

FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
por: Zechner, Rudolf, et al.
Publicado: (2012)

PPARγ as a sensor of lipase activity and a target for the lipase inhibitor orlistat
por: Martin, Harry, et al.
Publicado: (2013)

AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M
por: Tardelli, Matteo, et al.
Publicado: (2017)

PPARγ and LXR Signaling Inhibit Dendritic Cell-Mediated HIV-1 Capture and trans-Infection
por: Hanley, Timothy M., et al.
Publicado: (2010)

RXRα is Upregulated in First Trimester Endometrial Glands of Spontaneous Abortions Unlike LXR and PPARγ
por: Knabl, J., et al.
Publicado: (2016)

Sini Decoction Intervention on Atherosclerosis via PPARγ-LXRα-ABCA1 Pathway in Rabbits
por: Ju, Shicong, et al.
Publicado: (2018)

Shen-Hong-Tong-Luo Formula Attenuates Macrophage Inflammation and Lipid Accumulation through the Activation of the PPAR-γ/LXR-α/ABCA1 Pathway
por: Zhang, Zepeng, et al.
Publicado: (2020)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ(−/−), PPARδ(−/−), PPARγδ(−/−), or LXRαβ(−/−) bone marrow
por: Marathe, Chaitra, et al.
Publicado: (2009)

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis
por: Tardelli, Matteo, et al.
Publicado: (2019)

The Nuclear Receptor LXRα controls the functional specialization of splenic macrophages
por: A-Gonzalez, Noelia, et al.
Publicado: (2013)

Nuclear receptor LXRβ controls fitness and functionality of activated T cells
por: Michaels, Anthony J., et al.
Publicado: (2020)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

Effect of Aerobic Exercise on Lipid Metabolism in Rats With NAFLD
por: Zhou, Tongxi, et al.
Publicado: (2022)

Programmed cell death and lipid metabolism of macrophages in NAFLD
por: Xiao, Zhun, et al.
Publicado: (2023)

Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
por: Vitulo, Manuela, et al.
Publicado: (2023)

Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis
por: Feng, Ke, et al.
Publicado: (2021)

VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses
por: Brown, Jonathan D., et al.
Publicado: (2011)

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders
por: Hu, Ping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r69frvmfkqjm4h0r4doc68u7ne